Jump to content

WHO Expert Committee on Leprosy

Add links
From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Bender the Bot (talk | contribs) at 03:47, 27 December 2019 (→Reports: HTTP → HTTPS for Open Library, replaced: http://openlibrary.org/ → https://openlibrary.org/). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

WHO Expert Committee on Leprosy is constituted by World Health Organization to study the worldwide progress of Leprosy.

Reports

  • First report published as Technical Report Series No. 71 in 1954.
  • Second report published as Technical Report Series No. 189 in 1960.[1]
  • Third report published as Technical Report Series No. 319 in 1966.
  • Fourth report published as Technical Report Series No. 459 in 1970.
  • Fifth report published as Technical Report Series No. 607 in 1977.[2]
  • Sixth report published as Technical Report Series No. 768 in 1988.
  • Seventh report published as Technical Report Series No. 874 in 1998.[3] They concluded that a single dose of a combination of rifampicin, ofloxacin and minocycline is an acceptable and cost-effective alternative regimen for the treatment of single-lesion paucibacillary leprosy and the duration of the standard regimen for multibacillary leprosy could be shortened to 12 months.
  • Eighth report published as ISBN 978-92-4-120968-7 in 2012.

References

  1. ^ "Expert Committee on Leprosy (Open Library)". openlibrary.org. Retrieved 2015-01-01.
  2. ^ "WHO Technical Report Series No. 607" (PDF). whqlibdoc.who.int. Retrieved 2015-01-01.
  3. ^ WHO Expert Committee on Leprosy (1998). WHO Expert Committee on Leprosy: Seventh Report. World Health Organization. ISBN 9789241208741. Retrieved 2015-01-01.
Retrieved from "https://en.wikipedia.org/w/index.php?title=WHO_Expert_Committee_on_Leprosy&oldid=932608315"